Authors
Naomi Akagi, MD
Anne Deucher, MD, PhD
Yi Xie, MD, PhD
Department of Pathology and Laboratory Medicine
University of California San Francisco
San Francisco, California
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
· explain how clinical and laboratory findings fulfill criteria for clonal hematopoiesis of indeterminate potential (CHIP);
· describe the most common genetic mutations identified in patients with CHIP;
· apply the diagnostic criteria to correctly identify precursor entities such as idiopathic cytopenia of undetermined significance, idiopathic dysplasia of unknown significance, CHIP, and clonal cytopenia of undetermined significance; and
· discuss the clinical implications of recognizing these precursor conditions.